Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Q32 Bio (QTTB) Revenue (2018 - 2023)

Historic Revenue for Q32 Bio (QTTB) over the last 6 years, with Q4 2023 value amounting to -$1.4 million.

  • Q32 Bio's Revenue fell 26957.61% to -$1.4 million in Q4 2023 from the same period last year, while for Sep 2024 it was -$1.4 million, marking a year-over-year decrease of 11543.17%. This contributed to the annual value of $6.7 million for FY2023, which is 10732.54% up from last year.
  • Per Q32 Bio's latest filing, its Revenue stood at -$1.4 million for Q4 2023, which was down 26957.61% from $1.9 million recorded in Q3 2023.
  • In the past 5 years, Q32 Bio's Revenue ranged from a high of $29.3 million in Q1 2021 and a low of -$1.4 million during Q4 2023
  • For the 5-year period, Q32 Bio's Revenue averaged around $2.4 million, with its median value being $802000.0 (2021).
  • Per our database at Business Quant, Q32 Bio's Revenue skyrocketed by 488384.35% in 2021 and then crashed by 26957.61% in 2023.
  • Q32 Bio's Revenue (Quarter) stood at $563000.0 in 2019, then soared by 74.07% to $980000.0 in 2020, then fell by 18.16% to $802000.0 in 2021, then changed by 0.0% to $802000.0 in 2022, then plummeted by 269.58% to -$1.4 million in 2023.
  • Its Revenue stands at -$1.4 million for Q4 2023, versus $1.9 million for Q3 2023 and $3.2 million for Q2 2023.